Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aptiv PLC (APTV) vs TransMedics Group Inc (TMDX) Price & Performance

TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Aptiv PLC vs TransMedics Group Inc — how do they compare? Aptiv PLC trades at $50 (market cap $10.30B), while TransMedics Group Inc trades at $89.69 (market cap $3.10B). The key difference: Aptiv PLC is far larger — about 3.3× TransMedics Group Inc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Aptiv PLC nearer its low. Which is the better fit depends on your goals.

APTVTMDX
Market Cap
$10.30B$3.10B
Sector
Consumer CyclicalTechnology
52-Week High
$76.82$150.42
52-Week Low
$46.30$61.99
Enterprise Value
$15.23B$3.49B

Returns comparison

Trailing returns across standard periods

About Aptiv PLC

Aptiv's signal and power solutions segment supplies components and systems that make up a vehicle's electrical system backbone, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. The advanced safety and user experience segment provides body controls, infotainment and connectivity systems, passive and active safety electronics, advanced driver-assist technologies, and displays, as well as the development of software for these systems. Aptiv's largest customer is General Motors at roughly 12% of 2021 revenue, including sales to GM's Shanghai joint venture, followed by Stellantis at 11%, and Volkswagen at 9%. North America and Europe represented approximately 38% and 33% of total 2019 revenue, respectively.

Read more on APTV

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX